In the news
Prime Therapeutics sees drop in opioid claims
May 14, 2021Managed Healthcare Executive
Related news
In the news
April 18, 2024
Multiple Sclerosis Generics Switching Program Saves Millions
Specialty Pharmacy Continuum: A program in which managed care pharmacists reached out to healthcare providers in 2023 to advise them of potential cost savings that could accrue by switching their patients with multiple sclerosis (MS) from branded to generic therapies has generated significant savings
In the news
April 16, 2024
Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024
Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024